Cerevel Therapeutics
CERE
#1975
Rank
C$11.11 B
Marketcap
$60.98
Share price
0.00%
Change (1 day)
117.65%
Change (1 year)

EPS for Cerevel Therapeutics (CERE)

EPS in 2023 (TTM): -$3.37

According to Cerevel Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.39. In 2022 the company made an earnings per share (EPS) of -$3.15 a decrease over its 2021 EPS that were of -$2.24.

EPS history for Cerevel Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.377.09%
2022-$3.1540.61%
2021-$2.2436.84%
2020-$1.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$9.78-388.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.50-173.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.14-487.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.91-215.20%๐Ÿ‡บ๐Ÿ‡ธ USA